Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UltraGreen.ai is an AI-driven technology company focused on revolutionizing chemical synthesis for the pharmaceutical and life sciences sectors through sustainable green chemistry practices. The company utilizes advanced machine learning algorithms to predict and optimize chemical reactions, significantly reducing waste, energy usage, and the reliance on toxic solvents. By providing a platform for more efficient route scouting and process development, UltraGreen.ai enables drug manufacturers to lower costs and improve their environmental footprint. Their solutions are designed to accelerate the transition to sustainable manufacturing without compromising on yield or purity. The platform serves as a critical tool for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) aiming to meet rigorous ESG standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UltraGreen.ai.